Myasthenia gravis (MG) is an autoimmune disorder causing muscle weakness and fatigue due to antibodies targeting the acetylcholine receptor (AChR), muscle-specific kinase (MuSK), or related proteins at the...
CURATED BY: Jerrica Farias, MN, ARNP, PMHNP-BC
Jerrica R. Farias,
MN, ARNP, PMHNP-BC Nurse Practitioner, Associate Director of USF ALS Clinic at University of South Florida
Pilot Study Tests High-Dose Chemotherapy and Stem Cell Transplant in Treatment-Resistant Myasthenia Gravis
Myasthenia gravis (MG), characterized by autoantibodies disrupting neuromuscular junctions, was the focus of a pilot study examining high-dose chemotherapy (HDIT)...
Jerrica R. Farias,
MN, ARNP, PMHNP-BC Nurse Practitioner, Associate Director of USF ALS Clinic at University of South Florida
Study Highlights Differences in Autoantibody Functions Between ICI-Induced and Idiopathic Myasthenia Gravis
This study contrasts immune checkpoint inhibitor-induced myasthenia gravis (ICI-MG) with idiopathic MG by analyzing AChR autoantibodies. Among three patients with...
Jerrica R. Farias,
MN, ARNP, PMHNP-BC Nurse Practitioner, Associate Director of USF ALS Clinic at University of South Florida
Wearing Off Phenomenon in Ravulizumab Treatment for AChR gMG
A multicenter study is investigating a "wearing off" phenomenon in some patients with acetylcholine receptor antibody positive generalized myasthenia (AChR...
Jerrica R. Farias,
MN, ARNP, PMHNP-BC Nurse Practitioner, Associate Director of USF ALS Clinic at University of South Florida
Early Trial Shows CAR T-Cell Therapy’s Promise for patients With Myasthenia Gravis With Descartes-08
CAR T-cell therapy has emerged as a groundbreaking treatment for leukemia, lymphoma, and multiple myeloma, offering significant improvements and even...
Jerrica R. Farias,
MN, ARNP, PMHNP-BC Nurse Practitioner, Associate Director of USF ALS Clinic at University of South Florida
